SummerHaven Investment Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,130
Closed -$586K 256
2022
Q2
$586K Hold
18,130
0.4% 144
2022
Q1
$600K Buy
18,130
+815
+5% +$27K 0.34% 176
2021
Q4
$737K Hold
17,315
0.4% 160
2021
Q3
$767K Buy
+17,315
New +$767K 0.45% 155